Catalyst Funds Management Pty »

Zentalis Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $78k 51k 1.51
2025-06-30 $31k 27k 1.16
2024-06-30 $14k 3.5k 4.09
2024-03-31 $147k 9.3k 15.76

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Vanguard Group
Acadian Asset Management
Renaissance Technologies
Citadel Advisors
Tang Capital Management
Two Sigma Advisers
D. E. Shaw & Co
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
Morgan Stanley
GSA Capital Partners
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals